发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 170 |
| CHINA MAINLAND | 113 |
| Japan | 101 |
| France | 30 |
| Canada | 29 |
| GERMANY (FED REP GER) | 27 |
| South Korea | 27 |
| Italy | 25 |
| Spain | 20 |
| Brazil | 19 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| NATIONAL CANCER CENTER - JAPAN | 28 |
| UNIVERSITY OF TEXAS SYSTEM | 25 |
| UNICANCER | 21 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 20 |
| HARVARD UNIVERSITY | 17 |
| SARAH CANNON RESEARCH INSTITUTE | 17 |
| SHIZUOKA CANCER CENTER | 15 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 15 |
| UNIVERSITY OF ULSAN | 15 |
| DANA-FARBER CANCER INSTITUTE | 14 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Incidence of immune-related adverse events and its assoc... | 28 |
| Clinical toxicity of antibody drug conjugates: a meta-an... | 28 |
| Phase Ib/II study of gemcitabine, nab-paclitaxel, and pe... | 23 |
| Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the... | 22 |
| Radiomics to predict immunotherapy-induced pneumonitis: ... | 19 |
| Safety, pharmacokinetic, and pharmacodynamics of erdafit... | 18 |
| Emerging roles of non-coding RNAs in the pathogenesis, d... | 18 |
| Characteristics of patients with sorafenib-treated advan... | 15 |
| Multicenter retrospective analysis of the safety and eff... | 14 |
| Lopinavir-NO, a nitric oxide-releasing HIV protease inhi... | 13 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| CANCERS | 134 |
| INT J MOL SCI | 102 |
| EUR J MED CHEM | 71 |
| INVEST NEW DRUG | 66 |
| MOLECULES | 66 |
| FRONT ONCOL | 53 |
| CELLS-BASEL | 48 |
| CANCER CHEMOTH PHARM | 44 |
| SCI REP-UK | 42 |
| SEMIN CANCER BIOL | 37 |